These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3570029

  • 21. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
    Uribe-Esquivel M, Moran S, Poo JL, Muñoz RM.
    Scand J Gastroenterol Suppl; 1997; 222():49-52. PubMed ID: 9145447
    [Abstract] [Full Text] [Related]

  • 22. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
    Bircher J, Bührer M, Franz K, van Velthuijsen JA.
    Schweiz Med Wochenschr; 1982 Sep 18; 112(38):1306-7. PubMed ID: 7134954
    [Abstract] [Full Text] [Related]

  • 23. Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode.
    Mann NS, Borkar BB, Narenderan KP, Kadian RS, Mann SK, Martin RL.
    Am J Gastroenterol; 1979 Aug 18; 72(2):141-5. PubMed ID: 38663
    [Abstract] [Full Text] [Related]

  • 24. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R.
    Ned Tijdschr Geneeskd; 1978 Feb 11; 122(6):198-200. PubMed ID: 24187
    [No Abstract] [Full Text] [Related]

  • 25. Lactulose: a drug in search of a modus operandi.
    Conn HO.
    Gastroenterology; 1978 Mar 11; 74(3):624-6. PubMed ID: 24572
    [No Abstract] [Full Text] [Related]

  • 26. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I, Nemes B, Görög D, Gerlei Z, Kóbori L.
    Magy Seb; 2012 Apr 11; 65(2):58-62. PubMed ID: 22512880
    [Abstract] [Full Text] [Related]

  • 27. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt.
    Riggio O, Balducci G, Ariosto F, Merli M, Pieche U, Pinto G, Tremiterra S, Ziparo V, Capocaccia L.
    Dig Dis Sci; 1989 Jun 11; 34(6):823-9. PubMed ID: 2656134
    [Abstract] [Full Text] [Related]

  • 28. The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.
    Merli M, Caschera M, Piat C, Pinto G, Diofebi M, Riggio O.
    J Clin Gastroenterol; 1992 Sep 11; 15(2):125-7. PubMed ID: 1401823
    [Abstract] [Full Text] [Related]

  • 29. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL.
    Gastroenterology; 1977 Apr 11; 72(4 Pt 1):573-83. PubMed ID: 14049
    [Abstract] [Full Text] [Related]

  • 30. [Study of the laxative effect of Lactitol as opposed to lactulose in an open, randomized comparative study].
    Heitland W, Mauersberger H.
    Schweiz Rundsch Med Prax; 1988 May 03; 77(18):493-5. PubMed ID: 3051260
    [No Abstract] [Full Text] [Related]

  • 31. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J, Gmünder U, Haemmerli UP, Müller-Duysing W, Bally G, Haemmerli G, Hoffmann K.
    Strahlentherapie Sonderb; 1968 May 03; 67():330-6. PubMed ID: 5719130
    [No Abstract] [Full Text] [Related]

  • 32. The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose.
    Mortensen PB, Holtug K, Bonnén H, Clausen MR.
    Gastroenterology; 1990 Feb 03; 98(2):353-60. PubMed ID: 2295390
    [Abstract] [Full Text] [Related]

  • 33. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.
    Als-Nielsen B, Gluud LL, Gluud C.
    BMJ; 2004 May 01; 328(7447):1046. PubMed ID: 15054035
    [Abstract] [Full Text] [Related]

  • 34. Lactitol.
    Lancet; 1987 Jul 11; 2(8550):81-2. PubMed ID: 2885579
    [No Abstract] [Full Text] [Related]

  • 35. Lactulose, disaccharides and colonic flora. Clinical consequences.
    Clausen MR, Mortensen PB.
    Drugs; 1997 Jun 11; 53(6):930-42. PubMed ID: 9179525
    [Abstract] [Full Text] [Related]

  • 36. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ.
    Br J Clin Pract; 1981 Sep 11; 35(9):323-4. PubMed ID: 7326185
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A.
    Drugs; 2010 Jun 18; 70(9):1131-48. PubMed ID: 20518580
    [Abstract] [Full Text] [Related]

  • 38. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
    Watanabe M, Ozaki T, Hirata Y, Yoshikuni Y, Kimura K, Suzuki K, Sato S.
    Nihon Yakurigaku Zasshi; 1995 May 18; 105(5):389-402. PubMed ID: 7628787
    [Abstract] [Full Text] [Related]

  • 39. In hepatic coma, the problem comes from the colon, but will the answers come from there?
    Schafer DF.
    J Lab Clin Med; 1987 Sep 18; 110(3):253-4. PubMed ID: 3611947
    [No Abstract] [Full Text] [Related]

  • 40. Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.
    Bird SP, Hewitt D, Ratcliffe B, Gurr MI.
    Gut; 1990 Dec 18; 31(12):1403-6. PubMed ID: 2265782
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.